NUWE
NUWE
NASDAQ · Health Care

Nuwellis Inc

$3.08
-0.10 (-3.14%)
Financial Highlights (FY 2026)
Revenue
4.38M
Net Income
-9,279,252
Gross Margin
62.0%
Profit Margin
-211.9%
Rev Growth
-1.1%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.0% 62.0% 65.6% 65.6%
Operating Margin -134.3% -120.9% 16.7% 18.0%
Profit Margin -211.9% -201.3% 10.7% 13.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 4.38M 4.43M 456.0K 484.3K
Gross Profit 2.71M 2.74M 299.0K 317.5K
Operating Income -5,881,711 -5,350,793 76.2K 87.3K
Net Income -9,279,252 -8,441,652 48.7K 63.4K
Gross Margin 62.0% 62.0% 65.6% 65.6%
Operating Margin -134.3% -120.9% 16.7% 18.0%
Profit Margin -211.9% -201.3% 10.7% 13.1%
Rev Growth -1.1% -1.1% -2.2% -1.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.39M 1.38M
Total Equity 2.40M 2.33M
D/E Ratio 0.58 0.59
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -5,775,920 -5,546,471 88.9K 91.7K
Free Cash Flow 29.4K 36.1K